Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,205: | Line 1,205: | ||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari | |Mantle Cell Lymphoma||Disease||Mahsa Khanlari | ||
| | | | ||
| | |8/15/20 | ||
|PENDING | |||
| | | | ||
|SP | |SP | ||
| Line 1,214: | Line 1,214: | ||
| Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari | | Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari | ||
| | | | ||
| | |8/31/20 | ||
|PENDING | |||
| | | | ||
|SP | |SP | ||
| Line 1,223: | Line 1,223: | ||
| In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari | | In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari | ||
| | | | ||
| | |8/15/20 | ||
|PENDING | |||
| | | | ||
|SP | |SP | ||
| Line 2,166: | Line 2,166: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|8/10/18 | |8/10/18 | ||
| | | | ||
| Line 2,177: | Line 2,177: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|4/16/19 | |4/16/19 | ||
| | | | ||
| Line 2,188: | Line 2,188: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|6/9/19 | |6/9/19 | ||
| | | | ||
| Line 2,199: | Line 2,199: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|5/23/19 | |5/23/19 | ||
| | | | ||
| Line 2,210: | Line 2,210: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|8/6/18 | |8/6/18 | ||
| | | | ||
| Line 2,221: | Line 2,221: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
| Line 2,232: | Line 2,232: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
| Line 2,243: | Line 2,243: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
| Line 2,254: | Line 2,254: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
| Line 2,265: | Line 2,265: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
| Line 2,276: | Line 2,276: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
| Line 2,287: | Line 2,287: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||
| Line 2,298: | Line 2,298: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|12/5/18 | |12/5/18 | ||
| | | | ||
| Line 2,309: | Line 2,309: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|8/3/18 | |8/3/18 | ||
| | | | ||
| Line 2,320: | Line 2,320: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|6/9/19 | |6/9/19 | ||
| | | | ||
| Line 2,331: | Line 2,331: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|10/1/18 | |10/1/18 | ||
| | | | ||
| Line 2,342: | Line 2,342: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
|8/2/18 | |8/2/18 | ||
| | | | ||
| Line 2,353: | Line 2,353: | ||
| | | | ||
| | | | ||
|Complete | |Complete | ||
| | | | ||
| | | | ||